6/21/2024  5:19:47 PM Chg. -0.95 Volume Bid5:20:00 PM Ask5:20:00 PM Market Capitalization Dividend Y. P/E Ratio
108.50CHF -0.87% 43,355
Turnover: 4.69 mill.
-Bid Size: - -Ask Size: - 17.3 bill.CHF 0.78% 70.45

Business description

Headquartered in Basel, Switzerland, Straumann (SIX: STMN) is a global leader in implant, restorative and regenerative dentistry. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and biomaterials for use in tooth replacement and restoration solutions or to prevent tooth loss.
 

Management board & Supervisory board

CEO
Guillaume Daniellot
Management board
Dr. Peter Hackel, Camila Finzi, Wolfgang Becker, Jason Forbes , Holger Haderer, Patrick Loh , Alastair Robertson, Sébastien Roche, Aurelio Sahagun, Rahma Samow, Matthias Schupp, Dr Christian Ullrich
Supervisory board
Petra Rumpf, Dr. Beat Lüthi, Dr. Thomas Straumann, Marco Gadola, Regula Wallimann, Xiaoqun Clever-Steg, Stefan Meister, Olivier Filliol, Regula Wallimann
 

Company data

Name: Straumann Holding AG
Address: Peter Merian-Weg 12,CH-4052 Basel
Phone: +41-61-965-1111
Fax: +41-61-965-1101
E-mail: info@straumann.com
Internet: www.straumann.com
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 57.90%
IPO date: 1/1/1998

Investor relations

Name: Marcel Kellerhals
IR phone: +41 (0)61 965 17 51
IR Fax: -
IR e-mail: investor.relations@s...ann.com investor.relations@straumann.com

Company calendar

CW 33 | 8/14/2024 Interim Report 2nd Quarter/6 Months
CW 44 | 10/29/2024 Interim Report 3rd Quarter/9 Months
 

Main Shareholders

Others
 
60.40%
Dr h.c. Thomas Straumann
 
15.70%
Dr h.c. Rudolf Maag
 
10.20%
BlackRock Inc
 
7.20%
Simone Maag de Moura Cunha
 
3.50%
Gabriella Straumann
 
3.00%